Filippo Pietrantonio

89PUBLICATIONS
512CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Women's studies (incl. girls' studies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (89)

|Jul 24, 2026
Impact on survival of severe immuno-related adverse events in deficient mismatch repair/microsatellite instable-high digestive cancers treated with immunotherapy.

|Apr 25, 2026
Spatial predictors of response to chemo-immunotherapy in microsatellite stable metastatic colorectal cancer.

|Apr 21, 2026
Molecular Lineages of Sporadic Mismatch Repair-Deficient Colorectal Cancer.

|Apr 21, 2026
Amivantamab Monotherapy in Chemorefractory RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Results From OrigAMI-1, an Open-Label, Phase Ib/II Study.

|Apr 13, 2026
Circulating Tumor DNA Dynamics in Patients with Liver-Limited Metastatic Colorectal Cancer Resected after First-Line Systemic Treatment.

Roberto Moretto, Vittorio Studiale, Seung Won Hyun

|Mar 12, 2026
Reply to: Immune Checkpoint Blockade in Deficient Mismatch Repair/Microsatellite Instability-High Gastric Cancer: Solid Evidence or Premature Extrapolation?

Alberto Giovanni Leone, Alessandra Raimondi, Filippo Pietrantonio

Pageof 15

Frequent Collaborators

37 joint publications

Sara Lonardi

28 joint publications

Chiara Cremolini

16 joint publications

Federica Morano

14 joint publications

Paolo Manca